A summary of the update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Baddour Larry M, Epstein Andrew E, Erickson Christopher C, Knight Bradley P, Levison Matthew E, Lockhart Peter B, Masoudi Frederick A, Okum Eric J, Wilson Walter R, Beerman Lee B, Bolger Ann F, Estes N A Mark, Gewitz Michael, Newburger Jane W, Schron Eleanor B, Taubert Kathryn A, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Nursing, Council on Clinical Cardiology, Interdisciplinary Council on Quality of Care and Outcomes Research
Аннотация
METHODS AND RESULTS: The AHA commissioned this scientific statement to educate clinicians about CIED infections, provide explicit recommendations for the care of patients with suspected or established CIED infections and highlight areas of needed research. The recommendations in this statement reflect analyses of relevant literature, to include recent advances in our understanding of the epidemiology, risk factors, microbiology, management and prevention of CIED infections.
CONCLUSION: There are no scientific data to support the use of antimicrobial prophylaxis for dental or other invasive procedures.
CLINICAL IMPLICATIONS: The concerns about life-threatening drug reactions, the development of resistant strains of bacterial pathogens, medicolegal issues and cost to the health care system are, thus, avoided.